Skip to main content

Prefilled Syringes Market Size Worth USD 9.53 Billion at 10.4% CAGR; Rapid Development in Medical Devices Manufacturing in Asia-Pacific to Favor Market Growth: Fortune Business Insights™

Written by Customer Service on . Posted in Mergers And Acquisitions.

Pune, India, March 10, 2021 (GLOBE NEWSWIRE) — The global prefilled syringes market size is projected to reach USD 9.53 billion by 2026, exhibiting a CAGR of 10.4% during the forecast period. Rising incidence of cancer and other Non-Communicable Diseases (NCDs) is expected to be the primary factor fueling the prefilled syringe market growth. According to the World Health Organization (WHO), 9 million deaths are caused by cancer worldwide every year. In total, NCDs cause close to 41 million deaths, or 71% of the global deaths, annually, states the WHO.The National Cancer Institute estimates that in the US alone, 1,735,530 new cancer cases were reported in 2018; by 2030, this figure is anticipated to reach 23.6 million. Such widespread prevalence of cancer and other NCDs has generated the need for alternative solutions such as biological drugs. The administration of these drugs requires modern devices such as prefilled syringes, which is foreseen to augment the prefilled syringes market potential in the forthcoming years.Fortune Business Insights™ provides the above information in its new report, titled “Prefilled Syringes Market Size, Share & Industry Analysis, By Material (Glass and Plastic) By Closing System (Staked Needle System, Luer Cone System, and Luer Lock Form System) By Product (Complete Syringe Set and Components & Accessories) By Design (Double-chamber, Multiple-chamber, and Single-chamber) By End-user (Pharmaceutical & Biotechnology Companies, Contract Research & Manufacturing Organizations, and Others) and Regional Forecast, 2019-2026
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/prefilled-syringes-market-101946
Industry Developments:October 2019: The Aptar Group acquired the leader in patient onboarding and drug delivery devices, Nobel International, to diversify its service offerings for the biopharmaceutical industry. The acquisition will enable Aptar to support customers through all stages of their drug development process.December 2018: Terumo Corporation announced the launch of its product, Hulio®, which is a biosimilar to Humira® (adalimumab), in Europe. The drug is injected using Terumo’s PLAJEX™ pre-fillable syringe, giving the Japanese medical company an opportunity to make a footprint in the thriving prefilled syringes market of Europe.
Europe to Lead the Pack; Asia-Pacific to Grow at a Remarkable PaceAmong regions, Europe is slated to dominate the prefilled syringes market share during the forecast period, with the region’s market size having stood at USD 1.76 billion in 2018. Factors propelling the market in Europe include growing uptake of self-injectable drug devices and increasing preference for biological drugs for treating chronic diseases.Asia-Pacific is forecasted to showcase high-paced growth on account of increasing prevalence of chronic diseases and a speedily growing patient population. North America is projected to hold the second-largest section of the prefilled syringe market share owing to a strong presence of major market players and rising incidence of cancer.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/prefilled-syringes-market-101946
Rising Instances of Opportunistic Infections and Injuries at Hospitals to Boost the MarketInfections and injuries caused by needle sticks can be hazardous as they can cause serious damage to the body. According to the National Institute for Occupational Safety and Health (NIOSH), USA, a needle stick injury is one that is caused by sharp and pointed objects such as blood collection and hypodermic needles.Increasing workload of healthcare professionals at medical facilities such as hospitals has upped the threat of opportunistic injuries for these people, thereby expanding the prefilled syringes market size. For example, the US Centers for Disease Control and Prevention (CDC) numbered the injuries caused by sharp objects in US hospitals at 600,000. Thus, as patient care gets more complex and demanding, safety concerns regarding needle stick injuries are expected to gain prominence and lead the prefilled syringes market trends in the upcoming years.
Quick Buy Prefilled Syringes Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/101946
Product Diversification to be the Focus Area for CompetitorsKey players are putting in place different measures to gain a competitive edge, according to the prefilled syringes market analysis. While some companies are looking for ways to widen their product offerings, other participants are engaging in merger and acquisition activities to expand their presence in the market.
The Report Lists the Main Companies in this Market:BDGerresheimer AGAptarGroup, Inc.Helvoet Rubber & Plastic Technologies BVWest Pharmaceutical Services Inc.SCHOTT AGTerumo CorporationNipro PharmaPackaging InternationalOther Prominent Players
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/prefilled-syringes-market-101946
Detailed Table of Content:IntroductionResearch ScopeMarket SegmentationResearch MethodologyDefinitions and AssumptionsExecutive SummaryMarket DynamicsMarket DriversMarket RestraintsMarket OpportunitiesKey InsightsRegulatory Scenario by Key Countries/Key RegionOverview of Secondary Prefilled Containers such as Auto-injectors, Pens, etc.Prefilled Syringes Key Market TrendsOverview of Contract Research and Manufacturing Service Providers for Prefilled SyringesKey Industry Developments (Mergers, Acquisitions, Strategic Partnerships, Collaborations, etc.)Global Prefilled Syringes Market Analysis, Insights and Forecast, 2015-2026Key Findings / SummaryMarket Analysis, Insights and Forecast – By MaterialGlassPlasticMarket Analysis, Insights and Forecast – By Closing SystemStaked Needle SystemLuer Cone SystemLuer Lock Form SystemMarket Analysis, Insights and Forecast – By ProductComplete Syringe SetComponents & Accessories (Backstops, Plunger Stoppers, and Plunger Rods)Market Analysis, Insights and Forecast – By DesignSingle-chamberDouble-chamberMultiple-chamberMarket Analysis, Insights and Forecast – By End UserNorth America Prefilled Syringes Market Analysis, Insights and Forecast, 2015-2026Key Findings / SummaryMarket Analysis – By MaterialGlassPlasticMarket Analysis – By Closing SystemStaked Needle SystemLuer Cone SystemLuer Lock Form SystemMarket Analysis – By ProductComplete Syringe SetComponents & Accessories (Backstops, Plunger Stoppers, and Plunger Rods)Market Analysis – By DesignSingle-chamberDouble-chamberMultiple ChamberMarket Analysis, Insights and Forecast – By RegionNorth AmericaEuropeAsia PacificLatin AmericaMiddle East & AfricaPharmaceutical & Biotechnology CompaniesContract Research & Manufacturing OrganizationsOthersMarket Analysis, Insights and Forecast – By End UserMarket Analysis – By CountryU.S.CanadaPharmaceutical & Biotechnology CompaniesContract Research & Manufacturing OrganizationsOthersTOC Continued…!!
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/prefilled-syringes-market-101946
Have a Look at Related Reports:Injectable Cytotoxic Drugs Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Alkylating Drugs, Cytotoxic Antibodies, Antimetabolites, Plant Alkaloids, and Others), By Application (Oncology, Rheumatoid Arthritis, Multiple Sclerosis, and Others) By End-user (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Regional Forecast, 2020-2027Point-of-Care Coagulation Testing Devices Market Size, Share & COVID-19 Impact Analysis, By Device Type (Anticoagulation Monitoring Devices (PT-INR, ACT, aPTT), Platelet Function Monitoring Devices, Viscoelastic Coagulation Monitoring Devices (TEG, and ROTEM), and Others); By End User (Hospitals & Clinics, Homecare, and Others), Regional Forecast, 2020-2027Anxiety Disorders and Depression Treatment Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Antidepressants, Anxiolytics, Anticonvulsants, Noradrenergic Agents, and Atypical Antipsychotics), By Indication (Anxiety and Depression), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027Respiratory Syncytial Virus (RSV) Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Prophylaxis and Treatment), By End-user (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Regional Forecast, 2020-2027
About Us:Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:Fortune Business Insights™ Pvt. Ltd.308, Supreme Headquarters,Survey No. 36, Baner,Pune-Bangalore Highway,Pune – 411045, Maharashtra, India.Phone:US :+1 424 253 0390UK : +44 2071 939123APAC : +91 744 740 1245Email: sales@fortunebusinessinsights.comFortune Business Insights™LinkedIn | Twitter | Blogs
Press: https://www.fortunebusinessinsights.com/press-release/prefilled-syringes-market-9503

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.